NMRA · Neumora Therapeutics, Inc.
$1.60
-0.13 (-7.51%)
At close · Aug 14
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“the current available cash and cash equivalents will not be sufficient to fund the Company’s operating plans for at least twelve months from the issuance date of these condensed consolidated financial statements. Accordingly, the Company has concluded that substantial doubt exists about its ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$300.63M
Shares
187.90M
Weekly off-exchange (dark pool / OTC) trading volume reported to FINRA under its OTC/ATS Transparency data. ATS volume is executed on alternating trading systems (dark pools); non-ATS OTC is other over-the-counter dealer volume. The off-exchange share is total off-exchange volume as a percentage of consolidated weekly trading volume for the same Monday–Friday week.
Off-Exchange Volume History
| Week Start | ATS Volume | Non-ATS OTC Volume | Total Off-Exchange | % of FINRA Weekly Volume |
|---|---|---|---|---|
| 2026-07-06 | 1,113,705 | 1,040,413 | 2,154,118 | 34.3% |
| 2026-06-29 | 879,078 | 1,301,405 | 2,180,483 | 43.8% |
| 2026-06-22 | 2,374,535 | 4,044,442 | 6,418,977 | 29.6% |
| 2026-06-15 | 6,263,440 | 27,516,892 | 33,780,332 | 62.8% |
| 2026-06-08 | 706,022 | 932,146 | 1,638,168 | 41.7% |
| 2026-06-01 | 633,887 | 1,033,110 | 1,666,997 | 43.2% |
| 2026-05-25 | 630,334 | 1,014,272 | 1,644,606 | 39.3% |
| 2026-05-18 | 1,027,407 | 1,808,400 | 2,835,807 | 48.2% |
| 2026-05-11 | 932,346 | 2,373,994 | 3,306,340 | 52.6% |
| 2026-05-04 | 1,491,266 | 2,766,119 | 4,257,385 | 49.8% |
| 2026-04-27 | 2,245,759 | 2,572,917 | 4,818,676 | 54.1% |
| 2026-04-20 | 1,606,060 | 2,061,786 | 3,667,846 | 49.2% |
| 2026-04-13 | 1,498,300 | 1,921,462 | 3,419,762 | 54.9% |
| 2026-04-06 | 1,717,325 | 1,262,232 | 2,979,557 | 50.5% |
| 2026-03-30 | 2,003,966 | 1,999,964 | 4,003,930 | 45.5% |
| 2026-03-23 | 1,036,037 | 584,687 | 1,620,724 | 42.1% |
| 2026-03-16 | 592,354 | 1,022,475 | 1,614,829 | 48.2% |
| 2026-03-09 | 978,349 | 1,817,501 | 2,795,850 | 53.3% |
| 2026-03-02 | 782,073 | 1,230,593 | 2,012,666 | 40.2% |
| 2026-02-23 | 383,785 | 855,701 | 1,239,486 | 47.2% |
| 2026-02-16 | 813,441 | 1,664,034 | 2,477,475 | 42.4% |
| 2026-02-09 | 3,001,059 | 8,416,002 | 11,417,061 | 56.2% |
| 2026-02-02 | 657,734 | 1,017,685 | 1,675,419 | 46.6% |
| 2026-01-26 | 434,468 | 1,298,772 | 1,733,240 | 52.6% |
| 2026-01-19 | 472,531 | 1,666,177 | 2,138,708 | 50.4% |
| 2026-01-12 | 669,972 | 6,725,542 | 7,395,514 | 70.6% |
| 2026-01-05 | 3,773,921 | 11,853,089 | 15,627,010 | 56.0% |
| 2025-12-29 | 552,155 | 1,856,112 | 2,408,267 | 57.4% |
| 2025-12-22 | 665,581 | 1,551,118 | 2,216,699 | 55.8% |
| 2025-12-15 | 1,000,000 | 1,410,335 | 2,410,335 | 52.7% |
| 2025-12-08 | 550,812 | 1,113,746 | 1,664,558 | 52.9% |
| 2025-12-01 | 1,265,416 | 2,287,664 | 3,553,080 | 50.6% |
| 2025-11-24 | 858,762 | 2,001,043 | 2,859,805 | 64.4% |
| 2025-11-17 | 771,543 | 1,179,242 | 1,950,785 | 44.5% |
| 2025-11-10 | 919,023 | 1,986,670 | 2,905,693 | 49.0% |
| 2025-11-03 | 1,451,712 | 3,053,127 | 4,504,839 | 48.6% |
| 2025-10-27 | 2,607,497 | 14,040,829 | 16,648,326 | 58.5% |
| 2025-10-20 | 3,440,582 | 13,328,276 | 16,768,858 | 63.4% |
| 2025-10-13 | 352,512 | 860,771 | 1,213,283 | 55.4% |
| 2025-10-06 | 564,861 | 1,103,720 | 1,668,581 | 58.1% |
| 2025-09-29 | 256,896 | 1,010,804 | 1,267,700 | 48.8% |
| 2025-09-22 | 256,903 | 963,350 | 1,220,253 | 50.9% |
| 2025-09-15 | 250,580 | 1,210,343 | 1,460,923 | 47.6% |
| 2025-09-08 | 176,982 | 547,603 | 724,585 | 45.9% |
| 2025-09-01 | 167,695 | 566,389 | 734,084 | 47.5% |
| 2025-08-25 | 151,358 | 608,728 | 760,086 | 44.5% |
| 2025-08-18 | 379,542 | 720,336 | 1,099,878 | 56.5% |
Showing 1–47 of 47 weeks
Key facts
CIK
1885522
CUSIP
640979100
13F (30d)
114 filings
112 filers
Visit website
Investor relations